A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Clinical trial NCT02565511 · TERMINATED
Trial details
- NCT number
- NCT02565511
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-30
- Primary completion
- 2020-04-30
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.